Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. scores highest on Earnings (49) and lowest on Torque (16). Its PosiPenta is 31.23 out of 100, weaker than most similar companies.
On the Penta Grid this week, Neumora Therapeutics, Inc. is Grid #740 of 837 in the Healthcare sector in United States, and Grid #3,544 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Neumora Therapeutics, Inc. | 31.23 | 29 | 49 | 21 | 16 | 41 |
| Hyperfine, Inc. | 34.44 | 27 | 48 | 26 | 32 | 39 |
| Acrivon Therapeutics, Inc. | 42.54 | 42 | 32 | 43 | 54 | 42 |
| CareCloud, Inc. | 50.82 | 35 | 87 | 38 | 49 | 45 |
| Pelthos Therapeutics Inc. | 29.18 | 0 | 37 | 45 | 20 | 44 |
| Telomir Pharmaceuticals, Inc. | 39.98 | 4 | 58 | 55 | 40 | 43 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.39 |
| P/B ratio | 2.00 |
EEarnings
| Trailing EPS | ₹-116.50 |
| Forward EPS | ₹-63.40 |
NNitro
| Price | 44.88 |
| 52-week high | 345.71 |
| 52-week low | 29.84 |
| Fall from 52-week high | 87.0% |
TTorque
| Return on equity (ROE) | -187.11% |
| Debt-to-equity | 1.20 |
AAnchor
| Beta (price swings) | 2.98 |
| Market cap | ₹843 Cr |
| Insider holding | 23.08% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Neumora Therapeutics, Inc.'s PosiPenta score?
Neumora Therapeutics, Inc.'s PosiPenta is 31.23 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Neumora Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Neumora Therapeutics, Inc. is Grid #740 of 837 in the Healthcare sector in United States, and Grid #3,544 of 4,000 in United States.
Which PosiPenta pillar is strongest for Neumora Therapeutics, Inc.?
Earnings (growth), with a score of 49 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Neumora Therapeutics, Inc.?
Torque (durability), with a score of 16 out of 100: much weaker than most similar companies.
Has Neumora Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.28 points, from 27.95 to 31.23.
PositoAI is for research and education only and is not investment advice.